SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

JP Morgan Downgrades Atara Biotherapeutics to Neutral, Lowers Price Target to $22

JP Morgan downgrades Atara Biotherapeutics (NASDAQ:ATRA) from Overweight to Neutral and lowers the price target from $43 to $22.

Benzinga · -

JP Morgan downgrades Atara Biotherapeutics (NASDAQ:ATRA) from Overweight to Neutral and lowers the price target from $43 to $22.